To further understand the dynamics of the combined RT plus CSF-1R inhibition anti-glioma therapy, Akkari et al. (2020) [10] conducted an in-depth investigation of the dynamic changes in different tumor-associated macrophages (TAMs) in a randomized mouse study. This evidence concerns the gene CSF1R and central nervous system cancer.